Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (221-230 of 333) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|September 17, 2004
Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain geneYumiko Kanda-Akano, Kenichi Nomura, Yasuko Fujita, et al.
Journal of Virology|May 22, 2002
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core geneFuminaka Sugauchi, Etsuro Orito, Takafumi Ichida, et al.
The Journal of Pathology|December 15, 2005
Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutatedMegumi Yoshida, Mitsukuni Okabe, Tadaaki Eimoto, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2010
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma modelFumihiko Sato, Asahi Ito, Takashi Ishida, et al.
Blood|June 23, 2018
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|May 18, 2010
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reportsTatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, et al.
Molecular Cancer Therapeutics|June 21, 2008
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell linesEisaku Kondo, Takehiro Tanaka, Takayoshi Miyake, et al.
Blood|June 2, 2009
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarityJianmin Ding, Hirokazu Komatsu, Shinsuke Iida, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Pageof 34

Showing results (221-230 of 333) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|September 17, 2004
Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain geneYumiko Kanda-Akano, Kenichi Nomura, Yasuko Fujita, et al.
Journal of Virology|May 22, 2002
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core geneFuminaka Sugauchi, Etsuro Orito, Takafumi Ichida, et al.
The Journal of Pathology|December 15, 2005
Immunoglobulin VH genes in thymic MALT lymphoma are biased toward a restricted repertoire and are frequently unmutatedMegumi Yoshida, Mitsukuni Okabe, Tadaaki Eimoto, et al.
British Journal of Haematology|November 18, 2020
Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphomaYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
Cancer Immunology, Immunotherapy : CII|August 18, 2010
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi-scid, IL-2Rγ(null) mouse lymphoma modelFumihiko Sato, Asahi Ito, Takashi Ishida, et al.
Blood|June 23, 2018
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatmentYuma Sakamoto, Takashi Ishida, Ayako Masaki, et al.
International Journal of Hematology|May 18, 2010
Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reportsTatsuya Yoshida, Shigeru Kusumoto, Atsushi Inagaki, et al.
Molecular Cancer Therapeutics|June 21, 2008
Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell linesEisaku Kondo, Takehiro Tanaka, Takayoshi Miyake, et al.
Blood|June 2, 2009
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarityJianmin Ding, Hirokazu Komatsu, Shinsuke Iida, et al.
The Journal of Pathology. Clinical Research|October 6, 2020
Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphomaKeiichiro Fujii, Yuma Sakamoto, Ayako Masaki, et al.
Pageof 34